Bleselumab (INN; development code ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection. This drug was developed by…
Bleselumab (INN; development code ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.
This drug was developed by Kyowa Kirin, Inc.Statement On A Nonproprietary Name Adopted By The USAN Council - Bleselumab, American Medical Association.
References
Gebaseerd op: Wikipedia — Bleselumab · auteursgeschiedenis.
Tekst: CC BY-SA 4.0.
Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.